T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for STP938 in adults with relapsed or refractory B-cell and T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma [Phase 2]
Phase 2 study of ruxolitinib in relapsed or refractory T- or NK-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating GW5282 in combination with Golidocitinib (BEI-DOU3) for T-cell lymphoma; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of Tazemetostat in Lymphoid Malignancies [Phase 1]
Phase 1 study of tazemetostat in T-cell lymphoma has been terminated; sponsor University of Alabama at Birmingham is conducting this trial (…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating mogamulizumab in combination with DA-EPOCH or CHOEP for aggressive T-cell lymphoma and is currently r…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Enasidenib in People With T-Cell Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating enasidenib in people with T-cell lymphoma; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating CTX131 in adults with relapsed or refractory hematologic malignancies, assessing safety and efficacy …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) [Phase 2]
A Phase 2 pediatric trial is evaluating adding dasatinib or venetoclax to initial therapy to improve responses in newly diagnosed T-cell acu…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) [Phase 1, Phase 2]
This trial investigates BI-1808 as a single agent and in combination with pembrolizumab (Keytruda) for advanced malignancies, including ovar…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma [Phase 1]
This entry notes a Phase 1 clinical trial evaluating ONO-4685 in patients with relapsed or refractory T-cell lymphoma that is currently recr…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial evaluates PRT2527 as a standalone therapy and in combination with zanubrutinib or venetoclax for relapsed/refractor…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD4CAR for CD4+ Leukemia and Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CD4CAR as a CAR-T therapy for T-cell lymphoma and T-cell leukemia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas [Phase 2]
Phase 2 clinical trial update on using duvelisib as maintenance therapy after autologous stem cell transplant in T-cell lymphoma; the study …
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Novel Therapeutic Approach for Human T-cell Malignancies
A clinical trial update indicates a novel therapeutic approach is being investigated for adult T-cell leukemia/lymphoma and is currently rec…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma [Phase 1]
Treeline Biosciences is conducting a Phase 1 study of TLN-254 in participants with relapsed or refractory T-cell lymphoma, currently recruit…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: MB-105 in Patients With CD5 Positive T-cell Lymphoma [Phase 2]
This update reports a Phase 2 clinical trial of MB-105 for CD5-positive T-cell lymphoma, which is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating CD7 CAR-T therapy in combination with autologous hematopoietic stem cell transplantation for CD7-posi…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
This Phase 2 clinical trial is evaluating PI3K inhibitors for relapsed/refractory indolent T/NK-cell lymphomas and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]
This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple my…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of autologous stem cell transplantation combined with CD7-CART therapy for CD7-pos…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…